Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In this issue, there is a particular highlight on Outbreak Pathogens. In the past months, Jenner researchers have received major funding to manufacture and clinically develop vaccine candidates against several outbreak pathogens of international concern: Zika, Chikungunya, MERS and Rift Valley Fever. Recently, the Jenner Institute has also initiated research programmes on vaccines against non-communicable diseases such as prostate cancer and psoriasis, and Prof Lucy Dorrell’s group is utilizing the Jenner Institute’s viral vector prime-boost platform to deliver therapeutic vaccine against cervical pre-cancer.